| Novel dual inhibitors of vascular endothelial growth factor and VEGFR2 receptor JP Nguyen, CD Frost, ML Lane, WP Skelton IV, M Skelton, DL Vesely European journal of clinical investigation 42 (10), 1061-1067, 2012 | 27 | 2012 |
| Cardiac hormones target nuclear oncogenes c‐F os and c‐J un in carcinoma cells NJ Manimala, CD Frost, ML Lane, M Higuera, R Beg, DL Vesely European Journal of Clinical Investigation 43 (11), 1156-1162, 2013 | 26 | 2013 |
| Cardiac hormones are c-Jun-N-terminal kinase 2-inhibiting peptides ML Lane, O Santana, CD Frost, J Nguyen, J Guerrero, WP Skelton, ... Anticancer research 32 (3), 721-725, 2012 | 14 | 2012 |
| Potent selective inhibition of STAT 3 versus STAT 1 by cardiac hormones ML Lane, CD Frost, JP Nguyen, WP Skelton, M Skelton, DL Vesely Molecular and cellular biochemistry 371, 209-215, 2012 | 12 | 2012 |
| Reduction of leptin levels by four cardiac hormones: Implications for hypertension in obesity ML Lane, DL Vesely Experimental and Therapeutic Medicine 6 (2), 611-615, 2013 | 10 | 2013 |
| Subcutaneous pharmacokinetics of the cardiac hormone vessel dilator Q Zhou, G Whelan, SF Zhou, ML Lane, DL Vesely Clinical and Experimental Pharmacology and Physiology 41 (8), 565-570, 2014 | 1 | 2014 |
| SUBCUTANEOUS PHARMACOKINETICS OF NEW ANTICANCER AGENT VESSEL DILATOR D Vesely, Q Zhou, G Whelan, S Zhou, M Lane BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 115, 315-316, 2014 | | 2014 |
| Cardiac hormones are dual inhibitors of vascular endothelial growth factor and the VEGFR2 receptor JP Nguyen, CD Frost, ML Lane, WP Skelton, M Skelton, DL Vesely Endocrine Abstracts 29, 2012 | | 2012 |
